







ABSTRACT NR | THEME | NAME | SURNAME | TITLE |
001 | HIV & AIDS | Bronwyn L. | Ramsamy | Mechanisms Driving Colorectal Cancer (CRC) formation and differentiation in people with HIV (PWH) |
003 | Cancer immunology | Aviwe | Ntsethe | Impact of Protein Kinase C Activation and Monoclonal Antibodies on Immune Checkpoint Regulation and B Cell Function in Patients with Chronic Lymphocytic Leukemia |
015 | Cancer immunology | Doudou Georges Massar | Niang | TLR4 loss-of-function variants and neoadjuvant chemotherapy response in Senegalese women with breast cancer: exploratory evidence for African precision immunotherapy |
025 | Viral infections & vaccines | Abubakar Ojone | Woziri | Computational Evidence of Group A Rotavirus Viral Proteins Interaction with Host Receptors: Insights into Implications for Cross-species Rotavirus Vaccine Development in Africa |
027 | Autoimmunity & allergy | Aanuoluwapo H. | Williams | Serological And Molecular Profiling Of Selected Autoimmune Markers And Complement Factors Activity In Patients With Treatment-Resistant Schizophrenia |
034 | Helminths & other parasites | Alisha | Chetty | Migration of intestinal CD4+ T cells promote vaginal eosinophil accumulation following hookworm infection |
042 | Autoimmunity & allergy | Frédéric Christian | Diaz | Profile of Lymphocytic and Granulocytic Activities in senegalese patients with Atopic Dermatitis According to Disease Duration |
045 | Autoimmunity & allergy | Bineta | Ndiaye | Immunodetection of TSH-Receptor antibodies: A monocentric comparative study between ELISA and CLIA in Senegal |
048 | Tuberculosis | Vita | Nyasulu | BCG vaccination reshapes monocyte crosstalk in the immune microenvironment |
052 | Helminths & other parasites | Georgios | Petrellis | Helminth infection enhances host susceptibility to gammaherpesvirus coinfection via IL-4Rα-dependent changes in airway macrophages leading to syndecan 4 upregulation and impaired IFN-I response |
058 | Autoimmunity & allergy | Bineta | Ndiaye | Organ-specific autoimmunity: Insights on serological profiles of gastrointestinal and hepatic autoimmune diseases in Senegal |
066 | Tuberculosis | Elizabeth | Hlagala | The role of Pneumocystis murina in shaping host immunity and disease outcomes during viral (Pneumonia virus of mice) and bacterial (Mycobacterium tuberculosis) co-infection in mice |
070 | Autoimmunity & allergy | Adame | Diouf | High frequency of anti-Sm antibodies in an ANA-positive cohort: preliminary contribution of a method comparison study for anti-dsDNA detection |
072 | Immune mechanisms, diagnostics & innovation | Adame | Diouf | Impact of pre-analytical factors on antinuclear antibody testing by ELISA |
080 | HIV & AIDS | Mizinga Jacqueline | Tembo | The effect of in vitro vitamin D on CMV-specific T cell immune activation in adolescents living with HIV |
083 | HIV & AIDS | Amy | Parnell | CMV-associated immune alterations in young adults with perinatally-acquired HIV |
087 | Helminths & other parasites | Jeanne-Philippine | Mutangilayi | Uncovering the mechanisms regulating virtual memory T cells during helminth infection and bacterial coinfection |
107 | Immune mechanisms, diagnostics & innovation | Robert K. | Nyirenda | Shared and Site-Specific Immune Architecture Across Human Nasal and Female Genital Tract Mucosa |
115 | Bacterial & fungal infections | Lucian | Duvenage | Live-cell imaging reveals M1 macrophages restrict Emergomyces africanus intracellular replication |
119 | Cancer immunology | Vania T. A. | Maphossa | Fatty acids profile and association with acute leukemia survival in a Mozambican Pediatric Oncology Hospital Ward |
127 | HIV & AIDS | Andrea | Prinsloo | T-cell and monocyte immune dynamics in pregnant women living with HIV |
136 | Tuberculosis | Ndubuisi Johnkennedy | Madufor | Towards Simplified Immune Monitoring Using an Integrated Microfluidic Platform for Point-of-Care TB Diagnostics |
138 | Tuberculosis | Anneta F. | Naidoo | Optimization of an Intracellular Cytokine Staining (ICS) assay for detection of Th1 and Th17 cells to assess Mycobacterium tuberculosis vaccine responses in clinical trials |
140 | HIV & AIDS | Blessing | Moses | Assessing the impact of HIV exposure on T-cell responses to BCG vaccine in South African infants |
148 | HIV & AIDS | Joseph A. | Phiri | Persistent epithelial cell transcriptomic reprogramming in the nasal mucosa of PWH on long-term antiretroviral therapy |
153 | Viral infections & vaccines | Esemu Livo | Forgu | Early inflammation-driven damage and viral persistence associated with prolonged hepatic stress in a Cameroonian cohort of COVID-19 patients |
164 | HIV & AIDS | Wealth E. | Okete | HIV exposure alters anti-RSV antibody decay and protective breadth in infants |
166 | HIV & AIDS | Tafadzwa | Chimbetete | Spatial mapping of the skin immune microenvironment across HIV-related immunosuppression and antiretroviral therapy-mediated immune reconstitution. |
172 | Immune mechanisms, diagnostics & innovation | Salma | Sohbi | Development of an AI-powered chatbot for improving access to immunology knowledge on the Immunopaedia platform |
179 | HIV & AIDS | Nicole | Prins | CYTOMEGALOVIRUS INFECTION IN HIV-EXPOSED PRETERM INFANTS |
182 | HIV & AIDS | Carine | Kilola | Proteomic Profiling Identifies Paraoxonase-1 as a Potential Biomarker Linking Antiretroviral Therapy Timing to Placental Dysfunction in Pregnancies Affected by HIV |
191 | HIV & AIDS | Tafadzwa | Nerwande | The impact of inflammatory and metabolite breast milk profiles associated with maternal HIV on infant growth and development |
195 | Viral infections & vaccines | Zesuliwe | Jule | Omicron Reinfections Occur Without Loss of Neutralizing Antibodies or Respiratory Virus Immunity |
198 | Tuberculosis | Zizipo | Dlangayiya | Investigating the role of metallothionein (MT) genes in Mycobacterium tuberculosis killing by human myeloid cells |
201 | Immune mechanisms, diagnostics & innovation | Sadia | Tina | Pharmacological, Biological and Phytochemistry properties of Moroccan and Malian plant extracts from west and north Africa |
202 | Viral infections & vaccines | Eric | Ndombi | COVID-19 Pandemic Legacy: The Twin Challenge of Long COVID and Vaccine Hesitancy in the African context |
208 | HIV & AIDS | Levanco K. | Asia | Prevalence of HIV-1 Vpr amino acid variants associated with disease progression in cART-experienced South African people living with HIV |
213 | HIV & AIDS | Valencia M. | Chauke | Maternal integrase strand transfer inhibitor versus protease inhibitor use differentially shapes meconium composition in infants exposed to HIV |
223 | Maternal, neonatal & child immunology | Raymondo | Tossou | Optimization of Breast-Milk Macrophage Isolation, Polarization, and Functional Assessment for Maternal–Infant Immunology Studies |
227 | Immune mechanisms, diagnostics & innovation | Vishalini | Pillay | Clinical significance of the infiltration of leukocytes into seminal plasma and the downstream effects on sperm cells |
236 | HIV & AIDS | Carine | Kunsevi-Kilola | Maternal Plasma Proteomics Identifies PON1 as a Candidate Biomarker Linking HIV/ART Exposure to Placental Injury: A Pilot Study |
238 | HIV & AIDS | Tariq R. | Webber | Cytokine Dynamics Across Gestation in Pregnancies Complicated by HIV and Antiretroviral Therapy |
Presentation Guidelines
Oral Abstract Presentations will be 8-10 minutes in total.
TECHNICAL REQUIREMENTS
To guarantee your presentation will be displayed correctly, please note the following technical requirements and general notes:
- Use Office 365 PowerPoint. If you use MS PowerPoint, we recommend that you save your PowerPoint presentation using .pptx-format and not .ppsx.
- Kindly note that we cannot display a PDF file.
- Presentations must be formatted in a 16:9 aspect ratio.
- Use high contrasting lettering and fonts with a minimum size of 24pt and high contrast layouts like light text on dark colours. Only fonts which are included in the basic installation of MS-Windows 10 will be available (English version of Windows). Use of other fonts not included in Windows can cause the wrong layout/style of your presentation.
- Note that Apple Keynote presentations must be converted to PowerPoint. If you are a Mac-user, please use PowerPoint for Mac.
- Presentations will be projected in a minimum resolution of 1920 x 1080 pixels. All video/data projectors at the congress can utilize this resolution without a problem.
IMAGES AND VIDEOS
- Save the image you wish to use as a JPG or PNG and set compression/quality to medium or high. (Avoid saving images as TIF files, especially Mac presentations).
- Ensure that your videos are embedded within your presentation. Generally, the MPEG-4 and WMV format should work with no difficulties.
- Save the videos used in your presentation separately on a USB memory stick. In case of problems, we can re-insert the original items.
- Pictures and animation links to the internet or other files will NOT be accessible.
- All movies should be set to start automatically. If you require further information, please let me know so that we can assist.
- As a general rule, be careful to respect the rights of all authors and the anonymity of all individuals.
- Important, when you save your PowerPoint file, click on File>Options>Save>Embed fonts in the file. This will ensure that your fonts used won’t lose its formatting.
CONTENT STRATEGY ADVICE
We suggest a method which helps speakers get their message to the audience more effectively:
- Maximum of one clear idea or topic per slide.
- Concise slides by keeping text short and avoiding too many bullet points.
- Provide a new visual every minute.
- Use standard Windows fonts only: font size 24 can be read easily.
- Break your presentation into a series of 3-to-4-minute segments alternating storytelling and learning:
You will be able to facilitate slide transitions with an electronic slide-transition device. Please note that personal laptop computers or notebooks cannot be linked to the presentation system unless advance arrangements have been made. There will also be a comfort monitor in front of the stage where you will be able to see your slides. Presenter view is not supported.
SUBMISSION OF PRESENTATIONS
Please submit your final presentation, in Microsoft PowerPoint format, to me at [email protected] or via www.wetransfer.com or Google Drive by no later than Thursday 26 November 2026.
Presentations may also be submitted on arrival at the Congress, for uploading onto the presentation system. Please arrive at least 2 hours prior to your presentation.
- Poster presenters must print their own posters and bring them to the congress.
- Should you wish to have your poster printed by the Organisers in South Africa, the cost will be R650. To make payment, please click on this link: PAY NOW
- Once payment has been made, please send your poster in print-ready PDF to [email protected] by no later than 06 November 2026.
- The maximum poster size is A0 (approx. 84cm x 119cm).
- Posters must be printed on 180 gsm paper.
- Poster must not be laminated, or printed on material etc.
- Poster boards and the means to attach them will be provided by FAIS.
- The posters will be on display throughout the congress.
- Presenters have been notified of which poster session they are allocated to. Each poster presenter must stand by their poster and present it to interested audience members during their allocated session in the program.
- Poster Guidelines: http://colinpurrington.com/tips/academic/posterdesign/
With appreciation to our sponsors



